X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3072) 3072
Book Chapter (26) 26
Magazine Article (7) 7
Publication (3) 3
Book / eBook (1) 1
Dissertation (1) 1
Newsletter (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2791) 2791
science & technology (2122) 2122
life sciences & biomedicine (2063) 2063
female (1517) 1517
male (1454) 1454
middle aged (978) 978
aged (935) 935
cardiovascular system & cardiology (892) 892
antithrombins - adverse effects (842) 842
antithrombins - therapeutic use (833) 833
adult (701) 701
anticoagulants (595) 595
anticoagulants - adverse effects (576) 576
hematology (560) 560
anticoagulants - therapeutic use (537) 537
treatment outcome (530) 530
antithrombins - administration & dosage (523) 523
cardiac & cardiovascular systems (518) 518
abridged index medicus (507) 507
risk factors (506) 506
hemorrhage - chemically induced (491) 491
dabigatran (469) 469
peripheral vascular disease (459) 459
heparin - adverse effects (397) 397
aged, 80 and over (351) 351
animals (336) 336
blood coagulation - drug effects (326) 326
thrombin (321) 321
anticoagulants - administration & dosage (318) 318
recombinant proteins - therapeutic use (307) 307
antithrombin (305) 305
thrombosis (295) 295
time factors (294) 294
heparin - therapeutic use (283) 283
beta-alanine - analogs & derivatives (282) 282
atrial fibrillation - drug therapy (278) 278
benzimidazoles - adverse effects (278) 278
atrial fibrillation (268) 268
general & internal medicine (267) 267
antithrombin iii (258) 258
antithrombin iii - analysis (253) 253
heparin (252) 252
administration, oral (248) 248
dabigatran - adverse effects (247) 247
prospective studies (247) 247
surgery (244) 244
pharmacology & pharmacy (235) 235
adolescent (230) 230
peptide fragments - therapeutic use (230) 230
retrospective studies (228) 228
antithrombin iii - metabolism (223) 223
stroke (214) 214
beta-alanine - adverse effects (207) 207
thrombocytopenia - chemically induced (203) 203
stroke - prevention & control (202) 202
analysis (193) 193
bleeding (192) 192
care and treatment (192) 192
thromboembolism (191) 191
atrial fibrillation - complications (190) 190
thrombosis - etiology (190) 190
antithrombins - pharmacology (189) 189
dose-response relationship, drug (189) 189
recombinant proteins - adverse effects (188) 188
medicine, general & internal (187) 187
thrombosis - prevention & control (183) 183
hirudins - adverse effects (179) 179
drug therapy (174) 174
heparin - administration & dosage (172) 172
warfarin - adverse effects (160) 160
peptide fragments - adverse effects (158) 158
bivalirudin (156) 156
warfarin (155) 155
risk assessment (153) 153
patients (152) 152
blood coagulation tests (151) 151
coagulation (150) 150
medicine & public health (148) 148
platelet aggregation inhibitors - therapeutic use (148) 148
blood coagulation (147) 147
recombinant proteins - administration & dosage (147) 147
antithrombin iii - therapeutic use (144) 144
rivaroxaban (144) 144
stroke - etiology (144) 144
partial thromboplastin time (143) 143
benzimidazoles - therapeutic use (142) 142
warfarin - therapeutic use (142) 142
mortality (141) 141
anticoagulants - pharmacology (139) 139
dabigatran - therapeutic use (139) 139
drug therapy, combination (138) 138
hirudins - administration & dosage (135) 135
health aspects (134) 134
benzimidazoles - administration & dosage (132) 132
dabigatran - administration & dosage (132) 132
factor xa inhibitors (132) 132
fibrinolytic agents - therapeutic use (130) 130
randomized controlled trials as topic (130) 130
child (129) 129
pregnancy (128) 128
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2922) 2922
German (78) 78
French (48) 48
Japanese (37) 37
Spanish (21) 21
Russian (14) 14
Italian (13) 13
Polish (10) 10
Norwegian (8) 8
Danish (7) 7
Hungarian (7) 7
Portuguese (4) 4
Swedish (4) 4
Czech (3) 3
Bulgarian (2) 2
Chinese (2) 2
Turkish (2) 2
Arabic (1) 1
Finnish (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation (New York, N.Y.), ISSN 0009-7322, 07/2016, Volume 134, Issue 3, pp. 248 - 261
.... In addition to familiarity with the dosing and monitoring of vitamin K antagonists, clinicians are accustomed to using vitamin K if there is a need to reverse the anticoagulant effect of vitamin K antagonists... 
anticoagulants | atrial fibrillation | venous thromboembolism | hemorrhage | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Recombinant Proteins - therapeutic use | Plasma | Dabigatran - adverse effects | Pyrazoles - therapeutic use | Humans | Hemorrhage - prevention & control | Recombinant Proteins - adverse effects | Thiazoles - therapeutic use | Factor VIIa - therapeutic use | Arginine - analogs & derivatives | Dabigatran - therapeutic use | Thiazoles - adverse effects | Pyridines - adverse effects | Rivaroxaban - adverse effects | Factor Xa - therapeutic use | Rivaroxaban - therapeutic use | Factor Xa - adverse effects | Pyrazoles - adverse effects | Pyridines - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Administration, Oral | Antithrombins - therapeutic use | Piperazines - therapeutic use | Dabigatran - antagonists & inhibitors | Piperazines - adverse effects | Factor Xa Inhibitors - therapeutic use | Hemorrhage - drug therapy | Antithrombins - adverse effects | Factor Xa Inhibitors - adverse effects | Blood Coagulation Factors - therapeutic use | Arginine - adverse effects | Pyridones - therapeutic use | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Arginine - therapeutic use | Pyridones - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2014, Volume 179, pp. 279 - 287
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 02/2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Index Medicus | Abridged Index Medicus | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 09/2012, Volume 108, Issue 3, pp. 476 - 484
New oral anticoagulant drugs are emerging as alternatives to warfarin for the prevention of stroke in patients with non-valvular atrial fibrillation. Two... 
anticoagulants | Stroke | Atrial fibrillation | Review Article | Anticoagulants | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Thiophenes - therapeutic use | Pyrazoles - therapeutic use | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Warfarin - adverse effects | Male | Secondary Prevention | Dabigatran | Thrombophilia - etiology | Warfarin - therapeutic use | Rivaroxaban | Vitamin K - antagonists & inhibitors | Ischemic Attack, Transient - prevention & control | Clinical Trials, Phase III as Topic - statistics & numerical data | Heart Valve Diseases - complications | Female | Stroke - epidemiology | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Embolism - epidemiology | Morpholines - adverse effects | Morpholines - therapeutic use | Thrombophilia - drug therapy | Benzimidazoles - therapeutic use | Pyrazoles - adverse effects | Severity of Illness Index | Multicenter Studies as Topic - statistics & numerical data | Randomized Controlled Trials as Topic - statistics & numerical data | Stroke - prevention & control | beta-Alanine - adverse effects | Embolism - prevention & control | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Antithrombins - therapeutic use | Atrial Fibrillation - complications | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ischemic Attack, Transient - epidemiology | Antithrombins - adverse effects | Aged | Pyridones - therapeutic use | Hemorrhage - chemically induced | Pyridones - adverse effects
Journal Article
Archives of cardiovascular diseases, ISSN 1875-2136, 06/2013, Volume 106, Issue 6-7, pp. 382 - 393
Journal Article
The New England journal of medicine, ISSN 1533-4406, 05/2008, Volume 358, Issue 21, pp. 2218 - 2230
Journal Article
American Journal of Health-System Pharmacy, ISSN 1079-2082, 05/2013, Volume 70, Issue 10 Supplement 1, pp. S12 - S21
.... SUMMARYTo reverse the anticoagulant effects of warfarin in patients who are bleeding or need surgery, exogenous vitamin K (phytonadione... 
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Plasma | Anticoagulants - administration & dosage | Thiophenes - adverse effects | Thiophenes - antagonists & inhibitors | Humans | beta-Alanine - antagonists & inhibitors | Warfarin - adverse effects | Blood Coagulation Factors - administration & dosage | Hemorrhage - prevention & control | Dabigatran | Anticoagulants - antagonists & inhibitors | Rivaroxaban | Thromboembolism - prevention & control | Morpholines - antagonists & inhibitors | Antifibrinolytic Agents - administration & dosage | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Morpholines - adverse effects | Surgical Procedures, Operative - adverse effects | Pyrazoles - adverse effects | Blood Loss, Surgical - prevention & control | beta-Alanine - adverse effects | Administration, Oral | Warfarin - antagonists & inhibitors | Emergencies | Treatment Outcome | Pyridones - antagonists & inhibitors | Thromboembolism - etiology | Anticoagulants - adverse effects | Benzimidazoles - antagonists & inhibitors | International Normalized Ratio | Vitamin K 1 - administration & dosage | Antithrombins - adverse effects | Antithrombins - antagonists & inhibitors | Hemorrhage - chemically induced | Pyrazoles - antagonists & inhibitors | Pyridones - adverse effects | Drug metabolism | Complications and side effects | Anticoagulants (Medicine) | Research | Oral medication | Index Medicus
Journal Article
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, ISSN 2212-4403, 2012, Volume 113, Issue 4, pp. 431 - 441
Warfarin has been the primary anticoagulant drug used in the USA for more than 50 years. However, 2 novel types of oral anticoagulants have recently been... 
Surgery | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Half-Life | Warfarin - adverse effects | Biological Availability | Antithrombins - administration & dosage |